BioNTech
BNTX
296 hedge funds and large institutions have $5.24B invested in BioNTech in 2024 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 75 increasing their positions, 94 reducing their positions, and 64 closing their positions.
59% more capital invested
Capital invested by funds: $3.3B → $5.24B (+$1.94B)
17% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 64
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
16% more call options, than puts
Call options by funds: $367M | Put options by funds: $317M
3% more funds holding
Funds holding: 286 → 296 (+10)
1.35% more ownership
Funds ownership: 17.25% → 18.6% (+1.4%)
20% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 94
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$515M |
| 2 |
CII
Capital International Inc
Los Angeles,
California
|
+$67.3M |
| 3 |
FAM
Fred Alger Management
New York
|
+$46M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$32M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$25.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$269M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$76.8M |
| 3 |
Millennium Management
New York
|
-$57.9M |
| 4 |
Morgan Stanley
New York
|
-$43.4M |
| 5 |
DM
Deerfield Management
New York
|
-$38.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WTA
351
Washington Trust Advisors
Wellesley,
Massachusetts
| – | -$4.55K | -57 | Closed |
|
|
MG
352
Mather Group
Chicago,
Illinois
| – | -$4.24K | -46 | Closed |
|
|
CB
353
Chris Bulman
Roseville,
California
| – | -$3.62K | -45 | Closed |
|
|
RFG
354
RFP Financial Group
Atlanta,
Georgia
| – | -$2.09K | -26 | Closed |
|
|
VWWMG
355
Vermillion & White Wealth Management Group
Phoenixville,
Pennsylvania
| – | -$1.61K | -20 | Closed |
|
|
CFO
356
CVA Family Office
Denver,
Colorado
| – | -$964 | -12 | Closed |
|
|
OWA
357
Opal Wealth Advisors
Jericho,
New York
| – | -$884 | -11 | Closed |
|
358
Lazard Asset Management
New York
| – | -$644 | -7 | -50% |
|
BNTX Hedge Fund Activity: Q3 2024 in Review
296 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2024, worth a combined $5.24B — up 59% from $3.3B a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new BNTX positions and 64 closed out — a net gain of 11 holders — while 75 added to existing stakes and 94 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $515M. The largest seller was Harding Loevner, cutting an estimated $269M.
- 296 institutional investors held BioNTech (BNTX) as of Q3 2024, up from 286 in Q2 2024.
- Funds reported $5.24B of BioNTech stock for Q3 2024, up 59% quarter-over-quarter.
- 75 funds opened new BioNTech positions in Q3 2024 and 64 closed out, a net change of +11 holders.
- The largest BioNTech buyer in Q3 2024 was Fidelity Investments, an estimated $515M added.
- The largest BioNTech seller in Q3 2024 was Harding Loevner, an estimated $269M sold.
Based on aggregated 13F filings for Q3 2024.